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S U M M A R Y
Objectives: Herpes simplex virus type 1/2 (HSV-1/-2), cytomegalovirus (CMV), and Epstein–Barr virus
(EBV) correlate strongly with infections of the central nervous system. The objective of this study was to
develop a method for the simultaneous detection of HSV-1/-2, CMV, and EBV DNA by the ﬂuorescence
polarization assay based on asymmetric polymerase chain reaction (PCR) and hybridization.
Methods: DNA of HSV-1/-2, CMV, and EBV was ampliﬁed in an asymmetric PCR by a universal primer
system. The amplicons were then detected by the ﬂuorescence polarization assay. In this method, the
probes for HSV-1/-2, CMV, and EBV hybridized with their respective target amplicons, and the
hybridization resulted in an increase in the ﬂuorescence polarization values. Infections of HSV-1/-2,
CMV, and EBV were determined by the increased ﬂuorescence polarization values. The DNA extracted
from whole blood and cerebrospinal ﬂuid samples was subjected to ﬂuorescence polarization and a
previously published multiplex PCR assay in parallel.
Results: Compared to the multiplex PCR assay, no signiﬁcant difference in the numbers of samples
positive for the human herpesviruses was identiﬁed by the ﬂuorescence polarization assay.
Conclusions: The ﬂuorescence polarization assay presented in this study is a reliable, convenient, and
cost-effective diagnostic tool that allows the detection of the four major human herpesviruses.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Infections of the central nervous system are a difﬁcult
diagnostic problem for both clinicians andmicrobiologists. Various
clinical signs may be associated with infections caused by the four
major human herpesviruses (HHVs): herpes simplex virus type 1/2
(HSV-1/-2), human herpesvirus type 4 (cytomegalovirus, CMV),
and human herpesvirus type 5 (Epstein–Barr virus, EBV).1
Identiﬁcation of the DNA of the four major human herpesviruses
in whole blood and cerebrospinal ﬂuid (CSF) samples has become
themost direct and reliablemethod formonitoringHHV infections.
However, conventional detection methods for HSV-1/-2, CMV, and
EBV are not used in routine practice due to the complex
experimental process and high costs.2–6
A few ﬂuorescence polarization (FP) assays have been used as
the diagnostic method for the detection of particular organisms.7,8
The FP assay is simple as it can directly detect the hybridization* Corresponding author. Tel.: +86 029 84779626.
E-mail address: jianzhong@fmmu.edu.cn (Z. Ju).
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doi:10.1016/j.ijid.2010.03.023between the ﬂuorescent-labeled probes and the complementary
single-stranded DNA in polymerase chain reaction (PCR) pro-
ducts.9 In this studywe developed an FP assay for the simultaneous
detection of the four major human herpesviruses in whole blood
and CSF samples. Asymmetric PCR mainly generates single-
stranded DNA, which is more suitable for the hybridization–FP
assay than double-stranded DNA generated by symmetric PCR;10
hence single-stranded DNA was used in the current study.
2. Materials and methods
2.1. Primers and probes
A set of universal primers (H-GF and H-GR) within a highly
conserved region of the DNA polymerase gene from the four
herpesviruseswas designed byRozenberg and Lebon.11 The primers
span a polymorphic inner region and were used to amplify the
fragments of the DNA polymerase gene from HSV-1/-2, EBV, and
CMV. The four probes hybridized with one of the respective strands
of the amplicons of HSV-1/-2, EBV, and CMV were designed within
the target ampliﬁcation polymorphism regions of DNA polymeraseses. Published by Elsevier Ltd. All rights reserved.
Table 1
Primers and probes labeled
Genotype Sequence (50!30) Fluorescence labeled
H-GF gactttgccagcctgtacc
H-GR gtccgtgtccccgtagatg
HSV1-Probe caaggctcacgtgcgagagagcctcctc -FAM
HSV2-Probe gaaggcccacgtacgcgagagcctgctga -TAMRA
CMV-Probe gtatacagcgtcacgctagagaacggcgt -ROX
EBV-Probe cacgaaggccttggcccgctccaacatc -BTR
HSV, herpes simplex virus; CMV, cytomegalovirus; EBV, Epstein–Barr virus.
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information derived from NIH-GenBank. A database search (BLAST
from National Center for Biotechnology Information) of the probe
sequences revealed complete matches with their corresponding
herpesviruses. The four probes were labeled respectively with
TAMRA (carboxytetramethylrhodamine), FAM (carboxyﬂuores-
cein), ROX (carboxy-X-rhodamine), and BTR (BODIPY-Texas Red)
to differentiate the ampliﬁcation of HSV-1/-2, EBV, and CMV. All the
primers and probes were synthesized and labeled by Invitrogen
(Shanghai, China) (Table 1).
2.2. Controls, samples, and DNA extraction
The following prototype strainswereused in this research:CMV-
AD169 (ATCC VR-538), EBV (ATCC VRL-1612), andHSV-1/-2 (PG21).
HSV-1/-2 was cultivated in Vero cells, CMVwas cultivated in MRC5
diploid cells, and EBV was obtained from B95-8 cells. The DNA
isolated fromthe cellswas ampliﬁedusingH-GF andH-GR. The 518-
bpDNA fragments of the DNApolymerase gene ofHSV-1/-2, 524-bp
fragments of the DNA polymerase gene of EBV, and 589-bp
fragments of the DNA polymerase gene of CMV were cloned into
pGEM-T-easy vectors to construct recombinant plasmids (pGEM-T-
HSV-1, pGEM-T-HSV-2, pGEM-T-EBV, and pGEM-T-CMV) following
the manufacturer’s instructions (Promega, USA). The recombinant
plasmids were identiﬁed by sequence. After puriﬁcation of the
plasmids using a Wizard DNA Miniprep Kit (Promega, USA), the
amount of DNA was quantiﬁed by measuring the optical density at
260 nm, and the copy number was calculated. The plasmids were
serially diluted with HHV-negative plasma from a concentration of
1.0 1010 copies to 1.0 copy. The prepared plasmids and their
mixtureswere used as positive controls. The prepared pGEM-T-easy
vector plasmids were used as negative controls.
Genetically related virus DNA (human herpesvirus 6 and
varicella-zoster virus) isolated from infected cells and unrelated
virus DNA (plasmids of human papillomavirus and hepatitis B
virus) were used in the speciﬁcity analysis.
Whole blood samples from 350 screened blood donors (Blood
Bank, Shanxi, PLA), for which serological determination had been
performed by enzyme-linked immunosorbent assay (ELISA; IBL
International, Germany), were used as the control group. Whole
blood samples from 832 patients with clinically suspected
encephalitis or meningitis attending the Department of Neurology
of Xijing Hospital and the Department of Pediatrics of Tangdu
Hospital of the Fourth Military Medical University formed the
patient group. Three hundred and twenty-two CSF samples were
also collected from these patients.
EDTA peripheral blood and CSF sampleswere obtained from the
patients within 24 h of hospitalization, before antiviral therapy.
Total DNAwas extracted from 200ml of whole blood and CSF using
the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions and eluted in 60 ml of
TE buffer (10 mM Tris–HCl (pH 8.0) and 1 mM EDTA disodium
salt); samples were stored at 70 8C.
All the sampleswere checkedbyPCRassayusing primers speciﬁc
fora-tubulin to exclude the presence of inhibitors and to assess thequality and the integrity of the extracted DNA fromwhole blood or
CSF, as described previously.3 Ten of the 322 CSF samples
unampliﬁed by a-tubulin primers were excluded from the study.
2.3. DNA ampliﬁcation
All the positive and negative controls were subjected to
asymmetric PCR. An asymmetric PCR was carried out in 25ml
PCR reaction buffer containing 50 mM KCl, 10 mM Tris–HCl (pH
8.3), 2.5 mM MgCl2, 0.01% (wt/vol) gelatin, 5% dimethylsulfoxide,
5ml template DNA, 2.5 U Taq polymerase (Promega, USA), 0.2 mM
deoxynucleoside triphosphates (dNTP, each), and unequal
amounts of the two primers (10 pmol H-GF and 50 pmol H-GR
primers). The reaction mixture was incubated at 94 8C for 5 min.
Next, it was subjected to 45 cycles of incubation at 94 8C for 60 s to
denature the DNA, at 58 8C for 60 s to anneal the primers, and at
72 8C for 40 s to extend the annealed primers. Finally, it was
subjected to 94 8C for 60 s, 58 8C for 60 s, and cooled to 25 8C.
2.4. Simultaneous detection of the fourmajor human herpesviruses by
the FP assay
First, the asymmetric PCR products of the positive and negative
controls were detected by the FP assay with labeled probes, as
previously described, with some modiﬁcations.7 In brief, the
probes were diluted to 2.5 nM with TE buffer containing 0.8 M
NaCl. The positive hybridization contained a 200 ml mixture of the
four probes (50 ml, each) and 25ml of the asymmetric PCR
products generated from the positive controls. The negative
hybridization contained a 200ml mixture of the four probes and
25 ml of the asymmetric PCR products generated from the negative
controls. The mixes were incubated at 48 8C for 30 min and cooled
to 25 8C. Reactions were performed in duplicate. The FP values of
the reaction buffer were measured using the Fluorescence
Polarization Capable Instrument (YG-06, Yangguang, Shanxi,
China), as previously described.7
Next, the DNA extracted from each sample with successful
ampliﬁcationofa-tubulinwas subjected to asymmetric PCR and the
hybridization–FP assay. Each sample was analyzed in duplicate.
2.5. Detection of the fourmajor human herpesviruses by themultiplex
PCR assay
To conﬁrm the accuracy of the FP assay, the DNA extracted from
each sample with successful ampliﬁcation of a-tubulin was
subjected to the multiplex PCR assay as previously described.3
The positive samples that gave rise to amplicons of the predicted
size were excised and puriﬁed from the agarose gel using the DNA
Midi Puriﬁcation Kit (Tiangel, Beijing, China). The detection of the
four major human herpesviruses was achieved by digestion with
the restriction enzymes HpaII and Tru9I (Promega, USA).
3. Results
3.1. Cut-off values and the four major human herpesviruses in
samples
The average FP values (means) and the standard deviations (SD)
of the negative/positive controls for HSV-1/-2, CMV, and EBV are
shown in Table 2. The average FP values of the positive controls
were comparedwith the average FP values of the negative controls.
The average FP values (means) of the negative and the positive data
sets for HSV-1/-2, CMV, and EBV were signiﬁcantly different at a
99% level of conﬁdence in t-distribution tests. According to the
statistical certiﬁcation test (t-test), the cut-off values for each
target were assured at a conﬁdence level of >99%.7,12
Table 2
Fluorescence polarization values (units are millipolarization, mP) of controls and samples for herpesvirus types
Herpesvirus type FAM TAMRA ROX BTR
Negative controls (1.0–1.01010 copies)
pGEM-T-easy 34.421.7 46.791.9 57.232.5 36.231.9
Positive controls (1.0–1.01010 copies)
pGEM-T-HSV-1 126.514.5 55.863.94 64.874.98 43.332.7
pGEM-T-HSV-2 38.42.7 163.3395.6 68.744.94 48.213.5
pGEM-T-CMV 41.553.2 60.784.66 193.896.1 45.583.7
pGEM-T-EBV 40.93.5 57.664.67 65.374.7 143.764.9
Mixture of four plasmids 128.174.9 159.444.9 190.065.8 136.325.1
Whole blood (1182)
HSV1 (63) 1374.8 58.63.8 63.794.7 45.133.8
HSV2 (43) 39.73.9 164.95.6 69.845.2 49.884.3
CMV (145) 45.343.7 61.895.6 196.35.1 43.433.8
EBV (75) 37.43.6 58.874.7 66.284.9 154.556.4
Herpesvirus-negative (874) 41.772.9 54.352.6 62.664.4 46.822.7
CSF (312)
HSV1 (17) 144.54.7 60.43.4 65.74.9 484.9
HSV2 (11) 41.23.4 171.95.8 64.95.7 52.64.7
CMV (53) 44.43.6 63.35.4 201.65.7 53.44.6
EBV (13) 39.44.2 62.84.9 59.54.2 171.75.9
Herpesvirus-negative (224) 45.43.7 59.44.5 68.45.3 56.24.1
HSV, herpes simplex virus; CMV, cytomegalovirus; EBV, Epstein–Barr virus.
The ﬂuorescence polarization (FP) values are represented as mean standard deviation. The FP values units are millipolarization (mP). Results are stratied by herpesvirus types
and ﬂuorophores.
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was analyzed for the presence of HSV-1/-2, CMV, and EBV by the FP
assay. The average FP values of the sample were comparedwith the
average FP values of the negative controls. If the net change in the FP
value of a sample for FAMwas>38mP (units ofmillipolarization) of
thenegative control, the samplewas identiﬁedaspositive forHSV-1.
If the net change in the FP value of a sample for TAMRAwas>38mP
of the negative control, the sample was identiﬁed as positive for
HSV-2. If the net change in the FP value of a sample for ROXwas>42
mP of the negative control, the samplewas identiﬁed as positive for
CMV. If the net change in the FP value of a sample for BTR was >42
mP of the negative control, the samplewas identiﬁed as positive for
EBV. If therewas a great enoughnet change in the FP values formore
than one ﬂuorophore in a sample, the sample was identiﬁed as co-
infected (Table 3). For the positive samples, the FP value rangeswere
91–193 mP for HSV1, 114–242 mP for HSV2, 126–264 mP for CMV,
and 96–237 mP for EBV. The indeterminate samples after the ﬁrst
analysis were re-analyzed using the same method. There were no
equivocal results. The same infectionswere found in thepositive CSF
samples and their matched whole blood samples.
3.2. Analytical sensitivity
The sensitivity of the method was identiﬁed using serial diluted
plasmids. Analysis was performed with 20 replicates per concen-
tration level. The percent positivitywas calculated for each target at
every concentration level, particularly at the cut-off level. The
minimum level at which at least 95% of the reactions were positive
was 500 copies/ml for HSV-1/-2, EBV, and CMV, respectively.Table 3
Number of samples for herpesvirus types identiﬁed by ﬂuorescence polarization and m
Specimen FP
CMV EBV HSV1 HSV2 Co-in
Blood
Patient group (832) 142 75 61 43 17
Control group (350) 3 0 2 0 0
CSF
Patient group (312) 53 13 17 11 5
FP, ﬂuorescence polarization; CMV, cytomegalovirus; EBV, Epstein–Barr virus; HSV, he
Co-infection means that the sample was infected simultaneously with more than oneCompared with the multiplex PCR assay of Markoulatos et al. , a
higher sensitivity was observed with the FP assay.3
The sensitivity of the method for the detection of co-infections
was examined. HHV-negative plasma containing the plasmids
pGEM-T-HSV-1, pGEM-T-HSV-2, pGEM-T-EBV, and pGEM-T-CMV
were mixed in each of the following ratios: 25:25:25:25;
49:25:25:1; 25:49:1:25, and 1:25:25:49. The FP assay was able to
detect theminor population of HHV type evenwhen its contentwas
as low as 1%.
A panel of positive samples with different DNA concentrations
ranging from 1 to 500 ng was tested. The FP values were
sufﬁciently different from the negative controls across the entire
range of DNA template amounts.
3.3. Analytical speciﬁcity
The speciﬁcity of the primers was evaluated against unrelated
viruses (plasmids of human papillomavirus and hepatitis B virus)
and pGEM-T-easy vector in the presence of 10 mg of DNA extracted
from the HHV-negative plasma. None of them was ampliﬁed. This
suggests that the universal primers were highly speciﬁc and only
the target gene could be ampliﬁed efﬁciently.
The four probes exhibited strong speciﬁcity for their corre-
sponding herpesviruses. The assay was able to detect each viral
standard plasmid from 5 to 1  1010 copies per reaction without
cross-reaction in the presence of 1mg of DNA extracted from the
HHV-negative plasma.
Potential cross-reactivity was evaluated against other related
virus DNA (human herpesvirus 6 and varicella-zoster virus) in theultiplex PCR assay
Multiplex PCR
fection CMV EBV HSV1 HSV2 Co-infection
142 75 60 42 16
3 0 2 0 0
53 13 16 11 5
rpes simplex virus.
of the four major human herpesviruses.
W. Zhongliang et al. / International Journal of Infectious Diseases 14 (2010) e893–e897e896presence of 1mg of the DNA extracted from the HHV-negative
plasma. No cross-reaction was observed.
Clinical speciﬁcity was evaluated by analysis of 350 samples
from screened blood donors that were non-reactive for HHV by
immunoassay. CMV DNA was detected in three and HSV-1 DNA
was detected in two of the samples. Conﬁrmation of the results
was achieved by multiplex PCR assay.
3.4. Analytical stability
The serial diluted plasmids (5–1 1010 copies) of the positive/
negative controls were observed within run, run-to-run in three
nonadjacent laboratories. Analysis was performed with 10 repli-
cates per concentration level. Twenty-two repeat runs of the 10
replicates were performed at each site. The average FP values were
calculated at each concentration level. The assay of the FP values
indicated that there was excellent reproducibility in the method.
Reproducibility was evaluated using DNA extracted from 200
positive samples from the patient group and 100 negative samples
from the control group within run, run-to-run in three separate,
nonadjacent laboratories. The infection in each sample was the
same.
3.5. Comparison of the FP assay with the multiplex PCR assay
All samples were subjected to the FP andmultiplex PCR assay in
parallel. The detection of HSV-1/-2, EBV, and CMV infection based
on the FP and themultiplex PCR assaywas compared by Chi-square
test using SPSS v.10.0 software (SPSS Inc., Chicago, IL, USA). No
signiﬁcant difference in the numbers of samples positive for the
HHVs was identiﬁed between the two assays. Compared with the
multiplex assay, the sensitivity, speciﬁcity, negative predictive
value (NPV), and positive predictive value (PPV) of the FP assay for
the blood specimens of the two groups were 95%, 98%, 95%, and
98%, respectively; the sensitivity, speciﬁcity, NPV, and PPV for the
CSF specimens were 92%, 96%, 91%, and 96, respectively.
The discordant results for herpesvirus types between the two
assays were conﬁrmed using the nested PCR assay as described
previously.13
4. Discussion
We have described the detection of the four major human
herpesviruses in whole blood and CSF samples by the FP assay. A
comparison between the FP assay and the multiplex PCR assay
conﬁrmed the accuracy of the method in a large number of
samples. Of the blood samples in the control group non-reactive for
HHV by ELISA, three tested positive by the FP assay for CMV DNA
and two tested positive by the FP assay for HSV-1. This
demonstrates that the FP assay was more sensitive than the ELISA
for the detection of HSV and CMV,14 so it is more appropriate for
screening of samples that are non-reactive by immunoassay.
For the FP assay, the threshold concentrationwas dependent on
the target gene concentration. Sufﬁcient products were required
for the probes to bind entirely. There would be a lower net change
in a sample in which the probes are partially bound than in a
sample in which the probes are entirely bound. If only a small
number of amplicons was formed in a sample with a low
concentration of target gene, giving low FP values, such a sample
would be identiﬁed as negative.
The FP assay is reliant on the hybridization of label probe with
one strand of denatured PCR product. There are two competing
equilibria in the reaction.Theseare thebindingof theprobewithone
of the amplicon strands and the re-annealing of the two amplicon
strands.More re-annealing of the twoamplicon strands leavesmore
probe unbound. In our asymmetric PCR, a primer ratio of 1:5 and arather high number of 45 cycleswere used to ensure enough single-
stranded product and the high sensitivity of the FP assay. The
sensitivity of the assay makes it feasible for use in the detection of
latent multiplex herpesviruses, which correlate closely with
encephalitis and meningitis in infants and children. The FP assay
could help to guide the initiation of appropriate antiviral therapy.
The FP assay can be completed in less than 4 h as it requires no
separation, therefore the assay has the potential for real-time
clinical applicability. The FP assay uses much lower quantities of
reagents because the four types can be ampliﬁed by a single PCR
and the PCR product can be detected in a single tube. Such a
method is advantageous for the detection of viral encephalitis
agents, especially where small sample volumes make the
performance of multiple assays difﬁcult.
Several methods, such as the multiplex real-time PCR assay, are
now the preferred methodology. The minimum detection level of
the multiplex real-time PCR assay is 2 copies per reaction for EBV,
CMV, and HHV-6.15 Compared with the multiplex real-time PCR
method, a slightly lower sensitivity was observed with the FP
assay. The advantage of the FP assay is that it is cost-effective as it
does not require the instrument for real-time monitoring of
ampliﬁcation and the TaqMan probe; the cost of the probe used in
the FP assay is only 20% of that of a dual-labeled TaqMan probe.
Dual or triple infections of the central nervous system by two or
threeherpesviruseshavebeen reported.16 Therewasnodiscordance
between blood and CSF samples in this research. The feasibility of
doing a single CSF analysis given the low incidence of herpesvirus
encephalitis will be studied in a larger number of CSF samples.
The FP assay presented in this study could be a reliable,
convenient, and cost-effective diagnostic tool. However, this test in
its current formwill have most utility in the initial detection of the
four major human herpesvirus, and a lesser role in monitoring
diseases, which is currently often done by quantitative PCR. The
application of the FP assay in quantitative PCR will be studied in
the future.
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